Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1979 Apr;9(1):107-16.
doi: 10.1007/BF02024141.

Comparative effects of drugs on four paw oedema models in the rat

Comparative Study

Comparative effects of drugs on four paw oedema models in the rat

D K Gemmell et al. Agents Actions. 1979 Apr.

Abstract

The development of novel anti-inflammatory drugs (AID) has been claimed to be dependent on the discovery of models of inflammation that differ from those currently used for drug screening, e.g. carrageenen paw oedema and u.v. erythema. We have thus evaluated the effect of a variety of drugs in a number of novel models of inflammation in the rat produced in the hind paw. We have utilized kaolin, zymosan, anti-rat IgG (anti-IgG) and the Reversed Passive Arthus (RPA) reaction to produce these oedema models. We found that the non-steroidal AID's, e.g. aspirin, flufenamic acid, indomethacin, naproxen, and phenylbutazone, were active in all four tests. Of the nine novel AID examined, levamisole and tetramisole demonstrated considerable activity in all four tests and dapsone was especially active in the anti-IgG and RPA tests. In contrast, the anti-rheumatic d-penicillamine was inactive in all four models. Each of the ten compounds tested which has been claimed to influence complement function, was active in the RPA but not in the kaolin model. These results are discussed in the context of the aetiology of each oedema and the suspected mode of action of the various drugs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1969 Oct;103(4):866-8 - PubMed
    1. Eur J Pharmacol. 1976 Nov;40(1):1-8 - PubMed
    1. Agents Actions. 1973 Dec;3(5):348-56 - PubMed
    1. J Pharmacol Exp Ther. 1975 Jul;194(1):154-8 - PubMed
    1. J Exp Med. 1966 Sep 1;124(3):397-416 - PubMed

Publication types

LinkOut - more resources